saNOtize Research and Development Corp. news
SaNOtize Research and Development Corporation (“SaNOtize” or “the company”) today announced that it has been granted approval by Health Canada to conduct a multiCentre Phase II prevention and efficacy trial for a front-line antiviral prevention and early treatment for use against COVID-19.
SaNOtize also announced that new tests conducted by the Institute for Antiviral Research at Utah State University confirm SaNOtize’s Nitric Oxide Releasing Solution (NO
SaNOtize’s CEO, Dr. Gilly Regev, today announced that it will present at Biotech Showcase ™ 2018, to be held January 8–10 during the most important week in healthcare at the Hilton San Francisco Union Square.
Dr. Regev, CEO, will present at the Biotech Showcase™ as follows:
Date: 10th, January , 2018
Time: 9:15am (PST)
Room: Franciscan B